医疗保健和生命科学领域的全球 NLP 市场规模、份额和趋势分析：按技术、最终用途、地区和细分市场进行预测（2024-2030 年）

医疗保健和生命科学领域的 NLP 市场成长和趋势：

到2030年，全球医疗保健和生命科学领域的NLP市场规模预计将达到370亿美元。根据 Grand View Research, Inc. 的最新报告，预计在预测期内复合年增长率为 34.7%。市场的成长是由于对加强护理服务和病人参与的需求不断增长、对改善关键健康问题的预测分析的需求不断增长以及对增强临床决策支持的日益关注所致，这是由于对人工智能集成的投资增加。

对高阶临床决策支援不断增长的需求正在推动 NLP 在医疗保健和生命科学领域的采用。自然语言处理 (NLP) 提供了一种解决方案，能够从各种来源提取复杂信息，超出了传统临床决策支援系统的能力。这透过合併非结构化资料（例如医生叙述和患者笔记）来增强决策。 NLP 的整合旨在改善临床决策支持，更深入地了解患者资料，并最终促进更好的医疗保健结果和知情的医疗实践。例如，2030 年 11 月，健康资讯和分析领域的领导者 Elsevier Health 与 OpenEvidence 建立了策略合作伙伴关係，后者在医疗保健领域提供人工智慧功能。此次合作旨在开发 Clinical Key AI，这是一个先进的临床决策支援系统。该系统将最新的实证医学内容与先进的生成人工智慧相结合，在患者照护过程中为医疗保健专业人员提供帮助。该系统具有自然语言介面，可存取不断更新的基于证据的研究内容，这对于医疗保健环境中的培训和决策至关重要。

人工智慧 (AI) 和机器学习 (ML) 技术越来越多地用于准确的诊断过程，主要用于透过客製化的患者资料识别 COVID-19 阳性病例。 NCBI 在 2020 年发表的一项研究发现，人工智慧驱动的演算法成功识别了 25 名患者样本中 68% 的 COVID-19 阳性病例，这些病例最初被医护人员误诊为阴性。在医疗保健领域实施人工智慧和机器学习旨在改善患者治疗效果、最大限度地减少设备停机时间、降低医疗成本并促进市场扩张。疫情的爆发极大地促进了人工智慧主导的技术在患者和药物管理、诊断、系统互通性、索赔处理、工作流程增强和网路安全措施方面的整合。

此外，IBM、微软、Google（Alphabet Inc.）、IQVIA、Dolbey Systems, Inc.等市场主要企业正在采取产品发布、合作、扩张、联盟、併购等各种策略。透过这些策略倡议，市场公司正在努力加强其市场地位并扩大基本客群。例如，2023 年 4 月，Google云端宣布推出人工智慧理赔加速套件，以提高健康保险预先核准和申请处理的效率。该解决方案由 Claims Data Activator 提供支持，旨在透过将非结构化资料转换为结构化资料来减少健康计划和提供者的管理负担和成本。资料转换过程利用文件 AI、医疗保健自然语言 API 和医疗保健 API 等技术。这可以促进更快、更明智的决策，并有可能改善患者照护。

医疗保健和生命科学市场中的 NLP 报告亮点

• 根据技术，市场分为智慧援助、光学字元辨识、自动编码、文字分析、语音分析和分类/归类。智慧援助细分市场占最大市场占有率，2023年为18.71%。对加强患者照护和药物依从性的需求不断增长，推动了医疗保健产业对智慧援助的需求。
• 根据最终用途，市场分为提供者、付款人、生命科学公司等。 2023年，生命科学公司占了43.73%的重要市场占有率。
• 北美地区在 2023 年以 43.60% 的收益占有率占据市场主导地位。这是由于先进的医疗基础设施、支持性的政府政策、成熟的IT基础设施和高数位素养的存在。此外，亚太地区预计成长最快，2024年至2030年复合年增长率为37.0%。
• 该市场的着名公司包括 IBM、微软、Google (Alphabet)、IQVIA 和杜比系统。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 医疗保健与生命科学领域 NLP 市场的变数、趋势与范围

• 市场体系展望
  • 母市场展望
  • 相关/辅助市场展望
• 产业分析
  • 使用者观点分析
  • 主要最终用户
• 技术展望
• 法律规范
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
  • 产业挑战与机会分析
• 医疗保健和生命科学领域的 NLP 市场分析工具
  • 波特的分析
  • PESTEL分析
• 美国医疗保健付款人核心后台解决方案产业的关键交易和策略联盟分析
• COVID-19 的影响
• 案例研究：医疗保健和生命科学领域 NLP 市场的实际成功案例

第四章 医疗保健与生命科学领域的 NLP 市场：技术评估与趋势分析

• 定义和范围
• 技术市场占有率分析（2023/2030）
• 细分仪表板
• 医疗保健和生命科学领域的 NLP 市场：按技术分类（2018-2030）
• 智慧援助
• 光学字元辨识
• 自动编码
• 文字分析
• 语音分析
• 分类/分类

第五章医疗保健和生命科学领域的 NLP 市场：最终用途估计和趋势分析

• 定义和范围
• 最终用途市场占有率分析（2023/2030）
• 细分仪表板
• 医疗保健和生命科学领域的 NLP 市场：按最终用途分类（2018-2030）
• 提供者
• 付款人
• 生命科学公司
• 其他的

第六章医疗保健和生命科学领域的 NLP 市场：按国家、分布、应用和最终用途分類的区域估计和趋势分析

• 定义和范围
• 区域市场占有率分析（2023/2030）
• 区域市场仪表板
• 区域市场简介
• SWOT分析
• NLP 在医疗保健和生命科学领域的市场占有率：按地区划分（2023 年和 2030 年）
• 北美洲
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东/非洲

第七章 竞争格局

• 主要市场参与企业的最新趋势和影响分析
• 公司分类
• 公司市场占有率/地位分析
• 企业热力图分析
• 策略规划
  • 业务拓展
  • 併购
  • 伙伴关係与协作
  • 新技术引进
  • 研究与开发
• 公司简介
  • IBM
  • Microsoft
  • Google（Alphabet Inc.）
  • IQVIA
  • Dolbey Systems, Inc.
  • Averbis
  • Press ganey
  • lexalytics
  • Clinithink
  • Hewlett Packard Enterprise
  • Apixio
  • Edifecs
  • JohnSnow Labs
  • Itrex Group
  • Itrex Group
  • CloudMedx
  • BenevolentAI
  • Tempus

NLP In Healthcare And Life Sciences Market Growth & Trends:

The global NLP in healthcare and life sciences market size is expected to reach USD 37.0 billion by 2030. It is projected to grow at a CAGR of 34.7% over the forecast period, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the increasing demand to enhance care delivery and patient engagement, the growing need for predictive analytics to improve significant health concerns, the rising focus on enhancing clinical decision support, and the growing investment for AI integration in healthcare.

The increasing demand for advanced clinical decision support is driving the adoption of NLP in healthcare and life sciences. Natural Language Processing (NLP) offers a solution by enabling the extraction of complex information from various sources beyond the capabilities of conventional clinical decision support systems. This enhances decision-making by incorporating unstructured data, such as physician narratives and patient notes. Integrating NLP aims to improve clinical decision support, providing a more thorough understanding of patient data and ultimately facilitating better healthcare outcomes and well-informed medical actions. For instance, in November 2030, Elsevier Health, a medical information and analytics leader, entered a strategic alliance with OpenEvidence, a provider of artificial intelligence capabilities in the medical field. This collaboration aims to develop ClinicalKey AI, an advanced clinical decision support system. This system merges up-to-date, evidence-based medical content with advanced generative AI to assist healthcare professionals during patient care. It features a natural language interface that provides access to content alongside continuously updated evidence-based research crucial for medical training and decision-making at the point of care.

Artificial Intelligence (AI) and Machine Learning (ML) technologies were increasingly utilized for precise diagnostic processes, mostly in identifying COVID-19-positive individuals through tailored patient data. A study published by NCBI in 2020 demonstrated that AI-enhanced algorithms successfully identified 68% of COVID-19-positive cases within a sample of 25 patients, initially misdiagnosed as negative by medical practitioners. The deployment of AI and ML in healthcare aims to improve patient outcomes, minimize equipment downtime, and reduce medical costs, contributing to market expansion. The onset of the pandemic has significantly boosted the integration of AI-driven technologies in patient and medication management, diagnostics, system interoperability, claims handling, workflow enhancement, and cybersecurity measures.

Moreover, some of the key players in the market, such as IBM, Microsoft, Google (Alphabet Inc.), IQVIA, and Dolbey Systems, Inc., among others, are adopting various strategies such as product launches, partnerships, expansions, collaborations, and mergers & acquisitions. Through these strategic initiatives, market players are trying to strengthen their market positions and expand their customer base. For instance, in April 2023, Google Cloud introduced its AI-enabled Claims Acceleration Suite to enhance health insurance prior authorization and claims processing efficiency. Utilizing the Claims Data Activator, this solution aims to mitigate administrative burdens and reduce costs for health plans and providers by transforming unstructured data into structured data. It leverages technologies such as Document AI, Healthcare Natural Language API, and Healthcare API for data conversion processes. This facilitates quicker, more informed decision-making, potentially improving patient care.

NLP In Healthcare And Life Sciences Market Report Highlights:

• The market is segmented by technique into smart assistance, optical character recognition, auto coding, text analytics, speech analytics, and classification and categorization. The smart assistance segment held the largest market share of 18.71% in 2023. The increasing demand for enhanced patient care and medication adherence fuels the demand for smart assistance in the healthcare sector.
• Based on end use, the market is segmented into providers, payers, Life Science Companies, and others. Life Science Companies accounted for a significant market share of 43.73% in 2023, driven by the Increasing awareness regarding the benefits associated with the adoption of NLP.
• North America dominated the market with a revenue share of 43.60% in 2023. This is attributed to the presence of sophisticated healthcare infrastructure, supportive government policies, well-established IT infrastructure, and high digital literacy. Moreover, Asia Pacific is anticipated to witness the fastest growth at a CAGR of 37.0% from 2024 to 2030.
• Some of the notable companies in the market are IBM, Microsoft, Google (Alphabet Inc.), IQVIA, and Dolbey Systems, Inc., among others.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Technique Outlook
  • 2.2.2. End Use Outlook
• 2.3. Competitive Insights

Chapter 3. NLP in Healthcare and Life Sciences Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Industry Analysis
  • 3.2.1. User Perspective Analysis
  • 3.2.2. Key End Users
• 3.3. Technology Outlook
• 3.4. Regulatory Framework
• 3.5. Market Dynamics
  • 3.5.1. Market Drivers Analysis
  • 3.5.2. Market Restraints Analysis
  • 3.5.3. Industry Challenges and Opportunity Analysis
• 3.6. NLP in Healthcare and Life Sciences Market Analysis Tools
  • 3.6.1. Porter's Analysis
    • 3.6.1.1. Bargaining power of the suppliers
    • 3.6.1.2. Bargaining power of the buyers
    • 3.6.1.3. Threats of substitution
    • 3.6.1.4. Threats from new entrants
    • 3.6.1.5. Competitive rivalry
  • 3.6.2. PESTEL Analysis
    • 3.6.2.1. Political landscape
    • 3.6.2.2. Economic and Social landscape
    • 3.6.2.3. Technological landscape
    • 3.6.2.4. Environmental landscape
    • 3.6.2.5. Legal landscape
• 3.7. Major Deals & Strategic Alliances Analysis in the U.S. Healthcare Payers Core Administrative Processing Solutions Industry
• 3.8. Impact of COVID-19
• 3.9. Case Studies: Real-World Implementation Success Stories of NLP in Healthcare and Life Sciences Market

Chapter 4. NLP in Healthcare and Life Sciences Market: Technique Estimates & Trend Analysis

• 4.1. Definition and Scope
• 4.2. Technique Market Share Analysis, 2023 & 2030
• 4.3. Segment Dashboard
• 4.4. NLP in Healthcare and Life Sciences Market: By Technique, 2018 to 2030
• 4.5. Smart Assistance
  • 4.5.1. Smart Assistance Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.6. Optical Character Recognition
  • 4.6.1. Optical Character Recognition Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.7. Auto Coding
  • 4.7.1. Auto Coding Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.8. Text Analytics
  • 4.8.1. Text Analytics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.9. Speech Analytics
  • 4.9.1. Speech Analytics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.10. Classification and categorization
  • 4.10.1. Classification and categorization Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. NLP in Healthcare and Life Sciences Market: End Use Estimates& Trend Analysis

• 5.1. Definition and Scope
• 5.2. End Use Market Share Analysis, 2023 & 2030
• 5.3. Segment Dashboard
• 5.4. NLP in Healthcare and Life Sciences Market: By End Use, 2018 to 2030
• 5.5. Providers
  • 5.5.1. Providers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.6. Payers
  • 5.6.1. Payers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.7. Life Science Companies
  • 5.7.1. Life Science Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.8. Others
  • 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. NLP in Healthcare and Life Sciences Market: Regional Estimates & Trend Analysis by Country, Delivery, Application, End Use

• 6.1. Definition and Scope
• 6.2. Regional Market Share Analysis, 2023 & 2030
• 6.3. Regional Market Dashboard
• 6.4. Regional Market Snapshot
• 6.5. SWOT Analysis
  • 6.5.1. North America
  • 6.5.2. Europe
  • 6.5.3. Asia Pacific
  • 6.5.4. Latin America
  • 6.5.5. Middle East & Africa
• 6.6. NLP in Healthcare and Life Sciences Market Share, By Region, 2023 & 2030, USD Million
• 6.7. North America
  • 6.7.1. North America NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. U.S.
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Landscape/Reimbursement Scenario
    • 6.7.2.3. Competitive Insights
    • 6.7.2.4. U.S. NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Canada
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Landscape/Reimbursement Scenario
    • 6.7.3.3. Competitive Insights
    • 6.7.3.4. Canada NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.4. Mexico
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Regulatory Landscape/Reimbursement Scenario
    • 6.7.4.3. Competitive Insights
    • 6.7.4.4. Mexico NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Europe
  • 6.8.1. Europe NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. UK
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Landscape/Reimbursement Scenario
    • 6.8.2.3. Competitive Insights
    • 6.8.2.4. U.K. NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Germany
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Regulatory Landscape/Reimbursement Scenario
    • 6.8.3.3. Competitive Insights
    • 6.8.3.4. Germany NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. France
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Regulatory Landscape/Reimbursement Scenario
    • 6.8.4.3. Competitive Insights
    • 6.8.4.4. France NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Italy
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Regulatory Landscape/Reimbursement Scenario
    • 6.8.5.3. Competitive Insights
    • 6.8.5.4. Italy NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.6. Spain
    • 6.8.6.1. Key Country Dynamics
    • 6.8.6.2. Regulatory Landscape/Reimbursement Scenario
    • 6.8.6.3. Competitive Insights
    • 6.8.6.4. Spain NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.7. Sweden
    • 6.8.7.1. Key Country Dynamics
    • 6.8.7.2. Regulatory Landscape/Reimbursement Scenario
    • 6.8.7.3. Competitive Insights
    • 6.8.7.4. Sweden NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.8. Denmark
    • 6.8.8.1. Key Country Dynamics
    • 6.8.8.2. Regulatory Landscape/Reimbursement Scenario
    • 6.8.8.3. Competitive Insights
    • 6.8.8.4. Denmark NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.9. Norway
    • 6.8.9.1. Key Country Dynamics
    • 6.8.9.2. Regulatory Landscape/Reimbursement Scenario
    • 6.8.9.3. Competitive Insights
    • 6.8.9.4. Norway NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.9. Asia Pacific
  • 6.9.1. Asia Pacific NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.2. Japan
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Regulatory Landscape/Reimbursement Scenario
    • 6.9.2.3. Competitive Insights
    • 6.9.2.4. Japan NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.3. China
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Regulatory Landscape/Reimbursement Scenario
    • 6.9.3.3. Competitive Insights
    • 6.9.3.4. China NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.4. India
    • 6.9.4.1. Key Country Dynamics
    • 6.9.4.2. Regulatory Landscape/Reimbursement Scenario
    • 6.9.4.3. Competitive Insights
    • 6.9.4.4. India NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.5. Australia
    • 6.9.5.1. Key Country Dynamics
    • 6.9.5.2. Regulatory Landscape/Reimbursement Scenario
    • 6.9.5.3. Competitive Insights
    • 6.9.5.4. Australia NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.6. South Korea
    • 6.9.6.1. Key Country Dynamics
    • 6.9.6.2. Regulatory Landscape/Reimbursement Scenario
    • 6.9.6.3. Competitive Insights
    • 6.9.6.4. South Korea NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.7. Thailand
    • 6.9.7.1. Key Country Dynamics
    • 6.9.7.2. Regulatory Landscape/Reimbursement Scenario
    • 6.9.7.3. Competitive Insights
    • 6.9.7.4. Thailand NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.10. Latin America
  • 6.10.1. Latin America NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10.2. Brazil
    • 6.10.2.1. Key Country Dynamics
    • 6.10.2.2. Regulatory Landscape/Reimbursement Scenario
    • 6.10.2.3. Competitive Insights
    • 6.10.2.4. Brazil NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10.3. Argentina
    • 6.10.3.1. Key Country Dynamics
    • 6.10.3.2. Regulatory Landscape/Reimbursement Scenario
    • 6.10.3.3. Competitive Insights
    • 6.10.3.4. Argentina NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.11. Middle East and Africa
  • 6.11.1. Middle East and Africa NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.11.2. South Africa
    • 6.11.2.1. Key Country Dynamics
    • 6.11.2.2. Regulatory Landscape/Reimbursement Scenario
    • 6.11.2.3. Competitive Insights
    • 6.11.2.4. South Africa NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.11.3. Saudi Arabia
    • 6.11.3.1. Key Country Dynamics
    • 6.11.3.2. Regulatory Landscape/Reimbursement Scenario
    • 6.11.3.3. Competitive Insights
    • 6.11.3.4. Saudi Arabia NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.11.4. UAE
    • 6.11.4.1. Key Country Dynamics
    • 6.11.4.2. Regulatory Landscape/Reimbursement Scenario
    • 6.11.4.3. Competitive Insights
    • 6.11.4.4. UAE NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.11.5. Kuwait
    • 6.11.5.1. Key Country Dynamics
    • 6.11.5.2. Regulatory Landscape/Reimbursement Scenario
    • 6.11.5.3. Competitive Insights
    • 6.11.5.4. Kuwait NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Market Share/Position Analysis
• 7.4. Company Heat Map Analysis
• 7.5. Strategy Mapping
  • 7.5.1. Expansion
  • 7.5.2. Mergers & Acquisition
  • 7.5.3. Partnerships & Collaborations
  • 7.5.4. New Technique Launches
  • 7.5.5. Research And Development
• 7.6. Company Profiles
  • 7.6.1. IBM
    • 7.6.1.1. Participant's Overview
    • 7.6.1.2. Financial Performance
    • 7.6.1.3. Technology/Solutions Benchmarking
    • 7.6.1.4. Recent Developments
  • 7.6.2. Microsoft
    • 7.6.2.1. Participant's Overview
    • 7.6.2.2. Financial Performance
    • 7.6.2.3. Technology/Solutions Benchmarking
    • 7.6.2.4. Recent Developments
  • 7.6.3. Google (Alphabet Inc.)
    • 7.6.3.1. Participant's Overview
    • 7.6.3.2. Financial Performance
    • 7.6.3.3. Technology/Solutions Benchmarking
    • 7.6.3.4. Recent Developments
  • 7.6.4. IQVIA
    • 7.6.4.1. Participant's Overview
    • 7.6.4.2. Financial Performance
    • 7.6.4.3. Technology/Solutions Benchmarking
    • 7.6.4.4. Recent Developments
  • 7.6.5. Dolbey Systems, Inc.
    • 7.6.5.1. Participant's Overview
    • 7.6.5.2. Financial Performance
    • 7.6.5.3. Technology/Solutions Benchmarking
    • 7.6.5.4. Recent Developments
  • 7.6.6. Averbis
    • 7.6.6.1. Participant's Overview
    • 7.6.6.2. Financial Performance
    • 7.6.6.3. Technology/Solutions Benchmarking
    • 7.6.6.4. Recent Developments
  • 7.6.7. Press ganey
    • 7.6.7.1. Participant's Overview
    • 7.6.7.2. Financial Performance
    • 7.6.7.3. Technology/Solutions Benchmarking
    • 7.6.7.4. Recent Developments
  • 7.6.8. lexalytics
    • 7.6.8.1. Participant's Overview
    • 7.6.8.2. Financial Performance
    • 7.6.8.3. Technology/Solutions Benchmarking
    • 7.6.8.4. Recent Developments
  • 7.6.9. Clinithink
    • 7.6.9.1. Participant's Overview
    • 7.6.9.2. Financial Performance
    • 7.6.9.3. Technology/Solutions Benchmarking
    • 7.6.9.4. Recent Developments
  • 7.6.10. Hewlett Packard Enterprise
    • 7.6.10.1. Participant's Overview
    • 7.6.10.2. Financial Performance
    • 7.6.10.3. Technology/Solutions Benchmarking
    • 7.6.10.4. Recent Developments
  • 7.6.11. Apixio
    • 7.6.11.1. Participant's Overview
    • 7.6.11.2. Financial Performance
    • 7.6.11.3. Technology/Solutions Benchmarking
    • 7.6.11.4. Recent Developments
  • 7.6.12. Edifecs
    • 7.6.12.1. Participant's Overview
    • 7.6.12.2. Financial Performance
    • 7.6.12.3. Technology/Solutions Benchmarking
    • 7.6.12.4. Recent Developments
  • 7.6.13. JohnSnow Labs
    • 7.6.13.1. Participant's Overview
    • 7.6.13.2. Financial Performance
    • 7.6.13.3. Technology/Solutions Benchmarking
    • 7.6.13.4. Recent Developments
  • 7.6.14. Itrex Group
    • 7.6.14.1. Participant's Overview
    • 7.6.14.2. Financial Performance
    • 7.6.14.3. Technology/Solutions Benchmarking
    • 7.6.14.4. Recent Developments
  • 7.6.15. Itrex Group
    • 7.6.15.1. Participant's Overview
    • 7.6.15.2. Financial Performance
    • 7.6.15.3. Technology/Solutions Benchmarking
    • 7.6.15.4. Recent Developments
  • 7.6.16. CloudMedx
    • 7.6.16.1. Participant's Overview
    • 7.6.16.2. Financial Performance
    • 7.6.16.3. Technology/Solutions Benchmarking
    • 7.6.16.4. Recent Developments
  • 7.6.17. BenevolentAI
    • 7.6.17.1. Participant's Overview
    • 7.6.17.2. Financial Performance
    • 7.6.17.3. Technology/Solutions Benchmarking
    • 7.6.17.4. Recent Developments
  • 7.6.18. Tempus
    • 7.6.18.1. Participant's Overview
    • 7.6.18.2. Financial Performance
    • 7.6.18.3. Technology/Solutions Benchmarking
    • 7.6.18.4. Recent Developments

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 North America NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 4 North America NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 5 U.S. NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 6 U.S. NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 7 Canada NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 8 Canada NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 9 Mexico NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 10 Mexico NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 11 Europe NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 12 Europe NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 13 UK NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 14 UK NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 15 Germany NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 16 Germany NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 17 France NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 18 France NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 19 Italy NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 20 Italy NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 21 Spain NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 22 Spain NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 23 Sweden NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 24 Sweden NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 25 Denmark NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 26 Denmark NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 27 Norway NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 28 Norway NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 29 Asia Pacific NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 30 Asia Pacific NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 31 Japan NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 32 Japan NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 33 China NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 34 China NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 35 India NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 36 India NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 37 Australia NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 38 Australia NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 39 South Korea NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 40 South Korea NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 41 Thailand NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 42 Thailand NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 43 Latin America NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 44 Latin America NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 45 Brazil NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 46 Brazil NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 47 Argentina NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 48 Argentina NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 49 MEA NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 50 MEA NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 51 South Africa NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 52 South Africa NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 53 Saudi Arabia NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 54 Saudi Arabia NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 55 UAE NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 56 UAE NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
• Table 57 Kuwait NLP in Healthcare and Life Sciences market estimates and forecasts, by technique, 2018 - 2030 (USD Million)
• Table 58 Kuwait NLP in Healthcare and Life Sciences market estimates and forecasts, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 NLP in Healthcare and Life Sciences Market Segmentation
• Fig. 2 Information Procurement
• Fig. 3 Data Analysis Models
• Fig. 4 Market Formulation and Validation
• Fig. 5 Data Validating & Publishing
• Fig. 6 Market Snapshot
• Fig. 7 Segment Snapshot
• Fig. 8 Competitive Landscape Snapshot
• Fig. 9 NLP in Healthcare and Life Sciences Market Size and Growth Prospects (USD Billion)
• Fig. 10 NLP in Healthcare and Life Sciences Market: Market Dynamics
• Fig. 11 NLP in Healthcare and Life Sciences Market: PORTER's Analysis
• Fig. 12 NLP in Healthcare and Life Sciences Market: PESTEL Analysis
• Fig. 13 NLP in Healthcare and Life Sciences Market Share by Technique 2023 & 2030 (USD Billion)
• Fig. 14 NLP in Healthcare and Life Sciences Market,by Technique: Market Share, 2023 & 2030
• Fig. 15 Smart Assistance Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
• Fig. 16 Optical Character Recognition Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
• Fig. 17 Auto Coding Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
• Fig. 18 Text Analytics Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Speech Analytics Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Classification and categorization Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 21 NLP in Healthcare and Life Sciences Market, by End Use: Key Takeaways
• Fig. 22 NLP in Healthcare and Life Sciences Market, by End Use: Market Share, 2023 & 2030
• Fig. 23 Providers Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
• Fig. 24 Payers Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
• Fig. 25 Life Science Companies Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
• Fig. 26 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
• Fig. 27 NLP in Healthcare and Life Sciences Market Revenue, by Region, 2023 & 2030 (USD Million)
• Fig. 28 Regional Marketplace: Key Takeaways
• Fig. 29 Regional Marketplace: Key Takeaways
• Fig. 30 North America NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 31 U.S. NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Canada NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Mexico NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Europe NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 35 UK NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030) (USD Million)
• Fig. 36 Germany NLP in Healthcare and Life Sciences Market Estimates and Forecasts, (2018 - 2030) (USD Million)
• Fig. 37 France NLP in Healthcare and Life Sciences Market Estimates and Forecasts, (2018 - 2030) (USD Million)
• Fig. 38 Italy NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030) (USD Million)
• Fig. 39 Spain NLP in Healthcare and Life Sciences Market Estimates and Forecasts, (2018 - 2030) (USD Million)
• Fig. 40 Sweden NLP in Healthcare and Life Sciences Market Estimates and Forecasts, (2018 - 2030) (USD Million)
• Fig. 41 Denmark NLP in Healthcare and Life Sciences Market Estimates and Forecasts, (2018 - 2030) (USD Million)
• Fig. 42 Norway NLP in Healthcare and Life Sciences Market Estimates and Forecasts, (2018 - 2030) (USD Million)
• Fig. 43 Asia Pacific NLP in Healthcare and Life Sciences Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 44 Japan NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 45 China NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 46 India NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Australia NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 48 South Korea NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Thailand NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Latin America NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Brazil NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Argentina NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 53 MEA NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Saudi Arabia NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 55 South Africa NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 56 UAE NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Kuwait NLP in Healthcare and Life Sciences Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Key Company Categorization
• Fig. 59 Company Market Positioning
• Fig. 60 Key Company Market Share Analysis, 2023
• Fig. 61 Strategic Framework